Finance Home - My Yahoo - Yahoo! - Help

Friday, January 8, 2010, 9:01AM ET - U.S. Markets open in 29 mins.. Dow  0.31% Nasdaq  0.00%

Arena Pharmaceuticals, Inc. (ARNA)

On Jan 7: 3.54   0.00 (0.00%)

MORE ON ARNA

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Oct 26, 2009 • Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues Wall Street Transcript (Mon, Oct 26) • Sector Snap: Obesity drug makers gain ground AP (Mon, Oct 26) • Vivus' Mr. Wilson Goes To Washington at CNBC (Mon, Oct 26) • [video] Saving Health Care Dollars...and Lives at CNBC (Mon, Oct 26) • [video] The Battle Against Obesity at CNBC (Mon, Oct 26) • Arena Pharma rises on new lorcaserin trial data AP (Mon, Oct 26) • [video] Trimming the Health Care Fat at CNBC (Mon, Oct 26) • Early Movers: Pump Up the Volume at TheStreet.com (Mon, Oct 26) Sun, Oct 25, 2009 • Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation PR Newswire (Sun, Oct 25) Thu, Oct 22, 2009 • Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire (Thu, Oct 22) Wed, Oct 21, 2009 • ARENA PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online (Wed, Oct 21) Sat, Oct 17, 2009 • Medicine's Elusive Goal: A Safe Weight-Loss Drug at The New York Times (Sat, Oct 17) • Assessing the Chances for the Next Wave of Obesity Drugs at The New York Times (Sat, Oct 17) Mon, Oct 12, 2009 • 4-Star Stocks on the Upswing at Motley Fool (Mon, Oct 12) • Arena Pharmaceuticals' Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 PR Newswire (Mon, Oct 12) Fri, Oct 9, 2009 • Biotech Mailbag: Transdel Pharma at TheStreet.com (Fri, Oct 9) Thu, Oct 8, 2009 • 3 Stocks in a Tailspin at Motley Fool (Thu, Oct 8) Mon, Oct 5, 2009 • Tomorrow's Monster Stock? at Motley Fool (Mon, Oct 5) Wed, Sep 30, 2009 • 10 Stocks Shaking the Market at Motley Fool (Wed, Sep 30) • Onyx Pharma Holds Conference Call Too Late: BioBuzz at TheStreet.com (Wed, Sep 30) • Biotech Calendar: Key Dates and Events at TheStreet.com (Wed, Sep 30) • Orexigen Moves Forward With 2nd Obesity Drug: BioBuzz at TheStreet.com (Wed, Sep 30) Wed, Sep 23, 2009 • Beacon Equity Issues Technical Trading Overview for Arena Pharmaceuticals Inc. GlobeNewswire (Wed, Sep 23) Fri, Sep 18, 2009 • Stocks Up 2.2% for Week Amid Recovery Hopes at CNBC (Fri, Sep 18) • [video] Arena Soars: Stocks Search at TheStreet.com (Fri, Sep 18) Older Headlines - Most Recent Headlines View headlines from: Fri, Sep 18, 2009Fri, Sep 11, 2009Fri, Sep 4, 2009Fri, Aug 28, 2009Fri, Aug 21, 2009Fri, Aug 14, 2009Fri, Aug 7, 2009Fri, Jul 31, 2009Fri, Jul 24, 2009Fri, Jul 17, 2009 Add ARNA News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage